発熱性物質試験の世界市場(~2027)

• 英文タイトル:Pyrogen Testing Market Research Report by Component, Test Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Pyrogen Testing Market Research Report by Component, Test Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「発熱性物質試験の世界市場(~2027)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301H048
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、233ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の市場調査レポートでは、2021年の1,222.87百万ドルであった世界の発熱性物質試験市場規模が、2022年には1,375.29百万ドルへ到達し、2027年までにCAGR 12.64%増加して2,497.76百万ドルへ成長すると見込まれています。本調査レポートでは、発熱性物質試験の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、構成部品別(器具、キット、試薬)分析、試験種類別(エンドトキシン(LAL)試験、単球活性化試験(MAT)、ウサギ発熱性物質試験(RPT)、組換え因子Cアッセイ(RFC))分析、エンドユーザー別(バイオテクノロジー企業、医療機器企業、製薬企業)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報など、以下の構成でお届けいたします。なお、当レポートに記載されている会社情報にはAdmix Pharma Laboratories、bioMérieux SA、Charles River Laboratories International, Inc.、Corning Incorporated、Ellab A/S、Indoor Biotechnologies, Inc.、Lonza Group AG、MAT BioTech BV、Merck KGaA、Microcoat Biotechnologie GmbH、Minerva Analytix GmbHなどが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概
・市場インサイト
・世界の発熱性物質試験市場規模:構成部品別
- 発熱性物質試験器具の市場規模
- 発熱性物質試験キットの市場規模
- 発熱性物質試験試薬の市場規模
・世界の発熱性物質試験市場規模:試験種類別
- エンドトキシン(LAL)試験の市場規模
- 単球活性化試験(MAT)の市場規模
- ウサギ発熱性物質試験(RPT)の市場規模
- 組換え因子Cアッセイ(RFC)の市場規模
・世界の発熱性物質試験市場規模:エンドユーザー別
- バイオテクノロジー企業における市場規模
- 医療機器企業における市場規模
- 製薬企業における市場規模
・世界の発熱性物質試験市場規模:地域別
- 南北アメリカの発熱性物質試験市場規模
アメリカの発熱性物質試験市場規模
カナダの発熱性物質試験市場規模
ブラジルの発熱性物質試験市場規模
...
- アジア太平洋の発熱性物質試験市場規模
日本の発熱性物質試験市場規模
中国の発熱性物質試験市場規模
インドの発熱性物質試験市場規模
韓国の発熱性物質試験市場規模
台湾の発熱性物質試験市場規模
...
- ヨーロッパ/中東/アフリカの発熱性物質試験市場規模
イギリスの発熱性物質試験市場規模
ドイツの発熱性物質試験市場規模
フランスの発熱性物質試験市場規模
ロシアの発熱性物質試験市場規模
...
- その他地域の発熱性物質試験市場規模
・競争状況
・企業情報

The Global Pyrogen Testing Market size was estimated at USD 1,222.87 million in 2021 and expected to reach USD 1,375.29 million in 2022, and is projected to grow at a CAGR 12.64% to reach USD 2,497.76 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Pyrogen Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component, the market was studied across Instruments, Kits, and Reagents.

Based on Test Type, the market was studied across Limulus Amoebocyte Lysate (LAL) Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test (RPT), and Recombinant Factor C Assay (RFC).

Based on End User, the market was studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pyrogen Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pyrogen Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pyrogen Testing Market, including Admix Pharma Laboratories, bioMérieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Ellab A/S, Indoor Biotechnologies, Inc., Lonza Group AG, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Analytix GmbH, Nelson Laboratories, LLC by Sterigenics International LLC, Sanquin Reagents BV, and SOLVIAS AG.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Pyrogen Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pyrogen Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pyrogen Testing Market?
4. What is the competitive strategic window for opportunities in the Global Pyrogen Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Pyrogen Testing Market?
6. What is the market share of the leading vendors in the Global Pyrogen Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pyrogen Testing Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of infectious diseases and chronic diseases
5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical devices products
5.1.1.3. Rising number of government initiative for pharmaceutical and biotechnology industries
5.1.2. Restraints
5.1.2.1. High degree of consolidation
5.1.2.2. Issues and limited awareness about the advanced testing procedures
5.1.3. Opportunities
5.1.3.1. Increasing R&D in the pharmaceutical and biotechnology industries
5.1.3.2. Growing awareness of food safety
5.1.4. Challenges
5.1.4.1. Stringent government regulations
5.1.4.2. Issues related to harmful symptoms in patients with the use of pyrogen in therapeutics
5.2. Cumulative Impact of COVID-19

6. Pyrogen Testing Market, by Component
6.1. Introduction
6.2. Instruments
6.3. Kits
6.4. Reagents

7. Pyrogen Testing Market, by Test Type
7.1. Introduction
7.2. Limulus Amoebocyte Lysate (LAL) Test
7.3. Monocyte Activation Test (MAT)
7.4. Rabbit Pyrogen Test (RPT)
7.5. Recombinant Factor C Assay (RFC)

8. Pyrogen Testing Market, by End User
8.1. Introduction
8.2. Biotechnology Companies
8.3. Medical Device Companies
8.4. Pharmaceutical Companies

9. Americas Pyrogen Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Pyrogen Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Pyrogen Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Admix Pharma Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. bioMérieux SA
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Charles River Laboratories International, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Corning Incorporated
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Ellab A/S
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Indoor Biotechnologies, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Lonza Group AG
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. MAT BioTech BV
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Merck KGaA
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Microcoat Biotechnologie GmbH
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Minerva Analytix GmbH
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Nelson Laboratories, LLC by Sterigenics International LLC
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Sanquin Reagents BV
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. SOLVIAS AG
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing




• 英文レポート名:Pyrogen Testing Market Research Report by Component, Test Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:発熱性物質試験の世界市場(~2027)
• レポートコード:MRC2301H048お問い合わせ(見積依頼・ご注文・質問)